Alpha-2-Macroglobulin

Structure

Human α2-macroglobulin is composed of four identical subunits bound together by -S-S- bonds. In addition to tetrameric forms of α2-macroglobulin, dimeric, and more recently monomeric αM protease inhibitors have been identified.

Each monomer of human α2-macroglobulin is composed of several functional domains, including macroglobulin domains, a thiol ester-containing domain and a receptor-binding domain. Overall, α2-macroglobulin is the largest major nonimmunoglobulin protein in human plasma.

The amino acid sequence of α2-macroglobulin has been shown to be 71% the same as that of the pregnancy zone protein (PZP; also known as pregnancy-associated α2-glycoprotein).

Function

The α-macroglobulin (αM) family of proteins includes protease inhibitors, typified by the human tetrameric α2-macroglobulin (α2M); they belong to the MEROPS proteinase inhibitor family I39, clan IL. These protease inhibitors share several defining properties, which include (1) the ability to inhibit proteases from all catalytic classes, (2) the presence of a 'bait region' (also known as a sequence of amino acids in an α2-macroglobulin molecule, or a homologous protein, that contains scissile peptide bonds for those proteinases that it inhibits) and a thiol ester, (3) a similar protease inhibitory mechanism and (4) the inactivation of the inhibitory capacity by reaction of the thiol ester with small primary amines. αM protease inhibitors inhibit by steric hindrance. The mechanism involves protease cleavage of the bait region, a segment of the αM that is particularly susceptible to proteolytic cleavage, which initiates a conformational change such that the αM collapses about the protease. In the resulting αM-protease complex, the active site of the protease is sterically shielded, thus substantially decreasing access to protein substrates. Two additional events occur as a consequence of bait region cleavage, namely (1) the h-cysteinyl-g-glutamyl thiol ester becomes highly reactive and (2) a major conformational change exposes a conserved COOH-terminal receptor binding domain (RBD). RBD exposure allows the αM protease complex to bind to clearance receptors and be removed from circulation. Tetrameric, dimeric, and, more recently, monomeric αM protease inhibitors have been identified.

α2-Macroglobulin is able to inactivate an enormous variety of proteinases (including serine-, cysteine-, aspartic- and metalloproteinases). It functions as an inhibitor of fibrinolysis by inhibiting plasmin and kallikrein. It functions as an inhibitor of coagulation by inhibiting thrombin. α2-Macroglobulin has in its structure a 35 amino acid "bait" region. Proteinases binding and cleaving the bait region become bound to α2M. The proteinase–α2M complex is recognised by macrophage receptors and cleared from the system.

α2-Macroglobulin is known to bind zinc, as well as copper in plasma, even more strongly than albumin, and such it is also known as transcuprein. 10 to 15% of copper in human plasma is chelated by α2-macroglobulin.

Disease

α2-Macroglobulin levels are increased when the serum albumin levels are low, which is most commonly seen in nephrotic syndrome, a condition wherein the kidneys start to leak out some of the smaller blood proteins. Because of its size, α2-macroglobulin is retained in the bloodstream. Increased production of all proteins means α2-macroglobulin concentration increases. This increase has little adverse effect on the health but is used as a diagnostic clue.

An increase in α2-Macroglobulin with normal amount of albumin mainly indicates acute and/or chronic inflammation.

A common variant (29.5%) (polymorphism) of α2-macroglobulin may lead to increased risk of Alzheimer's disease. However, findings from meta-analyses have been inconclusive, and the association remains debated.

α2-Macroglobulin binds to and removes the active forms of the gelatinase (MMP-2 and MMP-9) from the circulation via scavenger receptors on the phagocytes.

References

References

1. (October 1995). "Low resolution X-ray structure of human methylamine-treated alpha 2-macroglobulin". Journal of Biological Chemistry.
2. (Jul 1984). "Primary structure of human alpha 2-macroglobulin. V. The complete structure.". Journal of Biological Chemistry.
3. (December 1998). "The phylogeny and evolution of the thioester bond-containing proteins C3, C4 and alpha 2-macroglobulin". Immunological Reviews.
4. (1999). "Alpha2-macroglobulin: an evolutionarily conserved arm of the innate immune system". Developmental and Comparative Immunology.
5. (Oct 2007). "Human alpha2-macroglobulin is composed of multiple domains, as predicted by homology with complement component C3.". The Biochemical Journal.
6. (Jan 1991). "Primary structure of pregnancy zone protein. Molecular cloning of a full-length PZP cDNA clone by the polymerase chain reaction". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression.
7. (July 1989). "Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation". Journal of Biological Chemistry.
8. (July 1989). "Proteinase binding and inhibition by the monomeric alpha-macroglobulin rat alpha 1-inhibitor-3". Journal of Biological Chemistry.
9. (February 1989). "A conserved region in alpha-macroglobulins participates in binding to the mammalian alpha-macroglobulin receptor". Biochemistry.
10. (December 1986). "Human pregnancy zone protein and alpha 2-macroglobulin. High-affinity binding of complexes to the same receptor on fibroblasts and characterization by monoclonal antibodies". Journal of Biological Chemistry.
11. (December 1993). "Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model". Infection and Immunity.
12. (September 2007). "Transcuprein is a macroglobulin regulated by copper and iron availability". The Journal of Nutritional Biochemistry.
13. (6 March 2006). "Transcupreins are serum copper-transporters of the macroglobulin family, and may be regulated by iron and copper". The FASEB Journal.
14. (January 1998). "Serum alpha 2-macroglobulin and alpha 1-inhibitor 3 concentrations are increased in hypoalbuminemia by post-transcriptional mechanisms.". Kidney International.
15. "Protein electrophoresis - serum".
16. (August 1998). "Alpha-2 macroglobulin is genetically associated with Alzheimer disease". Nature Genetics.
17. (July 2000). "alpha2-macroglobulin in late-onset Alzheimer's disease". Experimental Gerontology.
18. (2014-09-01). "Influence of Alpha-2-Macroglobulin 5bp I/D and Ile1000Val Polymorphisms on the Susceptibility of Alzheimers disease: A Systematic Review and Meta-analysis of 52 Studies". Cell Biochemistry and Biophysics.